Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dierks

Showing results (831-840 of 886) with videos related to

Pageof 89
Sort By:
The Journal of Infectious Diseases|July 17, 2025
Plasma Proteomics Reveals Distinct Signatures in Occult and Microfilaremic Loa loa InfectionsClemens Dierks, Pinkus Tober-Lau, Luzia Veletzky, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2026
Initial Clinical Experience with [<sup>177</sup>Lu]Lu-RTX-2358 Radiopharmaceutical Therapy Targeting Fibroblast Activation Protein: Biodistribution, Pharmacokinetics, and DosimetryLisa Glantschnig, Johanna S Enke, Bradley W Schuller, et al.
Thyroid : Official Journal of the American Thyroid Association|January 29, 2021
Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid CarcinomaChristine Dierks, Jochen Seufert, Konrad Aumann, et al.
Theranostics|August 15, 2022
Reduced splenic uptake on <sup>68</sup>Ga-Pentixafor-PET/CT imaging in multiple myeloma - a potential imaging biomarker for disease prognosisSabrina Kraus, Philipp Klassen, Malte Kircher, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 AgonistsNicholas R Wurtz, James A Johnson, Andrew Viet, et al.
ACS Pharmacology & Translational Science|October 21, 2022
Molecular Mechanisms of Desensitization Underlying the Differential Effects of Formyl Peptide Receptor 2 Agonists on Cardiac Structure-Function Post Myocardial InfarctionJohn Lupisella, Stéphane St-Onge, Marilyn Carrier, et al.
Veterinary Immunology and Immunopathology|December 6, 2008
The piglet as a model for B cell and immune system developmentJ E Butler, K M Lager, I Splichal, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 1, 2023
Automatic covariance pattern analysis outperforms visual reading of <sup>18</sup> F-fluorodeoxyglucose-positron emission tomography (FDG-PET) in variant progressive supranuclear palsyRalph Buchert, Florian Wegner, Hans-Jürgen Huppertz, et al.
EMBO Molecular Medicine|February 15, 2023
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiencyLars Schlotawa, Karolina Tyka, Matthias Kettwig, et al.
Journal of Medicinal Chemistry|March 5, 2008
Optimization of a dihydropyrrolopyrazole series of transforming growth factor-beta type I receptor kinase domain inhibitors: discovery of an orally bioavailable transforming growth factor-beta receptor type I inhibitor as antitumor agentHong-Yu Li, William T McMillen, Charles R Heap, et al.
Pageof 89

Showing results (831-840 of 886) with videos related to

Sort By:
Pageof 89
The Journal of Infectious Diseases|July 17, 2025
Plasma Proteomics Reveals Distinct Signatures in Occult and Microfilaremic Loa loa InfectionsClemens Dierks, Pinkus Tober-Lau, Luzia Veletzky, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2026
Initial Clinical Experience with [<sup>177</sup>Lu]Lu-RTX-2358 Radiopharmaceutical Therapy Targeting Fibroblast Activation Protein: Biodistribution, Pharmacokinetics, and DosimetryLisa Glantschnig, Johanna S Enke, Bradley W Schuller, et al.
Thyroid : Official Journal of the American Thyroid Association|January 29, 2021
Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid CarcinomaChristine Dierks, Jochen Seufert, Konrad Aumann, et al.
Theranostics|August 15, 2022
Reduced splenic uptake on <sup>68</sup>Ga-Pentixafor-PET/CT imaging in multiple myeloma - a potential imaging biomarker for disease prognosisSabrina Kraus, Philipp Klassen, Malte Kircher, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 AgonistsNicholas R Wurtz, James A Johnson, Andrew Viet, et al.
ACS Pharmacology & Translational Science|October 21, 2022
Molecular Mechanisms of Desensitization Underlying the Differential Effects of Formyl Peptide Receptor 2 Agonists on Cardiac Structure-Function Post Myocardial InfarctionJohn Lupisella, Stéphane St-Onge, Marilyn Carrier, et al.
Veterinary Immunology and Immunopathology|December 6, 2008
The piglet as a model for B cell and immune system developmentJ E Butler, K M Lager, I Splichal, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 1, 2023
Automatic covariance pattern analysis outperforms visual reading of <sup>18</sup> F-fluorodeoxyglucose-positron emission tomography (FDG-PET) in variant progressive supranuclear palsyRalph Buchert, Florian Wegner, Hans-Jürgen Huppertz, et al.
EMBO Molecular Medicine|February 15, 2023
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiencyLars Schlotawa, Karolina Tyka, Matthias Kettwig, et al.
Journal of Medicinal Chemistry|March 5, 2008
Optimization of a dihydropyrrolopyrazole series of transforming growth factor-beta type I receptor kinase domain inhibitors: discovery of an orally bioavailable transforming growth factor-beta receptor type I inhibitor as antitumor agentHong-Yu Li, William T McMillen, Charles R Heap, et al.
Pageof 89